SCHEMBL129340

SCHEMBL129340

[CH2]c1cncs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL28299249 0.69
SCHEMBL2842864 0.63
Thiazole-5-Carbaldehyde SCHEMBL1316528 0.63 PIM1 (0.42)
Thiazole-5-Carbaldehyde SCHEMBL194323 0.63
SCHEMBL544073 0.63
SCHEMBL5752803 0.63 KMT2A (0.47)
SCHEMBL2840541 0.63
SCHEMBL290048 0.62
SCHEMBL1162452 0.62
SCHEMBL276437 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 924 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230364115-A1 NOVEL PSYCHEDELIC COMPOSITIONS, DELIVERY SYSTEMS AND THERAPEUTIC USES THEREOF MYDECINE INNOVATIONS GROUP INC (US) 2023-11-16 US claimed
EP-4273147-A1 SUBSTITUTED SPIROLACTAMS, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2023-11-08 EP claimed
CN-116234546-A GPX4 inhibitors, pharmaceutical compositions thereof and their use in the treatment of GPX4 mediated diseases 嘉兴优博生物技术有限公司 2023-06-06 CN claimed
US-20230132298-A1 OXABOROLE ESTERS AND USES THEREOF ANACOR PHARMACEUTICALS, LLC 2023-04-27 US claimed
US-11578087-B2 Oxaborole esters and uses thereof ANACOR PHARMACEUTICALS, INC. (US) 2023-02-14 US claimed
CN-115417829-A Preparation method of ritonavir enantiomer 武汉海特生物创新医药研究有限公司 2022-12-02 CN claimed
US-11186596-B2 Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses ADT PHARMACEUTICALS, LLC (US) 2021-11-30 US claimed
WO-2021183702-A1 GPX4 INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING GPX4-MEDIATED DISEASES EUBULUS BIOTHERAPEUTICS INC. (CN) 2021-09-16 WO claimed
US-20210220333-A1 COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING FILARIAL DISEASE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2021-07-22 US claimed
EP-3846817-A1 COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING FILARIAL DISEASE The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (US) 2021-07-14 EP claimed
US-5683999-A Cyclic urea HIV protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-11-04 US claimed
WO-1996029329-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-26 WO claimed
US-5395838-A Aromatic aminomethyl substitutes compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-03-07 US claimed
US-5393875-A Hypotensive, cardiotonic and antiischemic agents HOFFMANN-LA ROCHE INC. (US) 1995-02-28 US claimed
EP-0373891-B1 Anti-tumour agents ICI PLC (GB) 1994-11-02 EP claimed
US-5189165-A PROCESS FOR THE PREPARATION OF 1,1-DISUBSTITUTED CYCLOPROPANE DERIVATIVES HOECHST AKTIENGESELLSCHAFT (DE) 1993-02-23 US claimed
EP-0509354-A2 Amino acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 1992-10-21 EP claimed
EP-0435151-A2 Process for the preparation of 1,1-disubstituted cyclopropane derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1991-07-03 EP claimed
EP-0373891-A2 Anti-tumour agents IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-20 EP claimed
EP-0237917-A2 1,1-Disubstituted cyclopropane derivatives, processes for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-09-23 EP claimed